Education
About Us
Working with TipRanks
Follow Us
Cresco Labs OTC (TSE:CL)
:CL
Earnings Data
Report Date
Mar 18, 2026Before Open (Not Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.03Last Year’s EPS
0Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted Cresco Labs' stable financial performance and strategic market expansions, including debt refinancing and market gains in Ohio and Germany. However, ongoing challenges such as price compression and the impact of higher cost flower on margins, along with the exit from California operations, presented notable lowlights.Company Guidance
Stable Financial Performance
Cresco Labs reported $165 million in revenue, representing a 1% sequential increase from Q2. Adjusted gross profit was $80 million, and adjusted EBITDA was $40 million, indicating stable financial performance despite market challenges.
Debt Refinancing Success
The company successfully completed debt refinancing, reducing the size of the debt, extending maturities, and improving flexibility to fund future growth.
Strategic Market Expansion
Cresco Labs is expanding its operations in Ohio, holding the #1 retail share position and opening new dispensaries. The company is also entering the Kentucky market with a cultivation and processing facility and launching in Germany to test its brand strategy in the European Union.
Wholesale Market Gains
Wholesale revenue grew 10% quarter-over-quarter, driven by expanded capacity and strong market share gains in Illinois and Pennsylvania, with the company achieving #1 branded share positions in these states and Massachusetts.
Retail Technology Innovations
Sunnyside, a retail brand of Cresco Labs, rolled out self-serve kiosks to improve transaction speed and optimize staffing, leading to faster checkouts and higher customer satisfaction.
TSE:CL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:CL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | C$1.51 | C$1.56 | +3.31% |
Aug 07, 2025 | C$0.93 | C$0.96 | +3.23% |
May 30, 2025 | C$0.93 | C$0.84 | -9.68% |
Mar 12, 2025 | C$1.07 | C$1.06 | -0.93% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cresco Labs OTC (TSE:CL) report earnings?
Cresco Labs OTC (TSE:CL) is schdueled to report earning on Mar 18, 2026, Before Open (Not Confirmed).
What is Cresco Labs OTC (TSE:CL) earnings time?
Cresco Labs OTC (TSE:CL) earnings time is at Mar 18, 2026, Before Open (Not Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:CL EPS forecast?
TSE:CL EPS forecast for the fiscal quarter 2025 (Q4) is -0.03.